Entering text into the input field will update the search result below

Moderna, Inc. (MRNA) Management Presents at Piper Sandler 33rd Annual Virtual Healthcare Brokers Conference (Transcript)

Dec. 01, 2021 5:15 PM ETModerna, Inc. (MRNA)
SA Transcripts profile picture
SA Transcripts

Moderna, Inc. (NASDAQ:MRNA) Piper Sandler 33rd Annual Virtual Healthcare Conference December 1, 2021 2:00 PM ET

Company Representatives

Stephen Hoge - President

Conference Call Participants

Ted Tenthoff - Piper Sandler

Ted Tenthoff

Good afternoon, everyone. My name is Ted Tenthoff, I’m the Senior Biotechnology Analyst at Piper Sandler and thanks for joining us for this year's Virtual Healthcare Conference. Sorry for the slight delay, but as you guys know, Stephen Hoge, President of Moderna literally is on the front lines of fighting Omicron, so we are going to jump right in.

Question-and-Answer Session

Q - Ted Tenthoff

Stephen, what can you tell us about this new variant and routine protection by the current vaccines?

Stephen Hoge

Well, first of all I want to say thank you Ted, and we’ll jump right in of course. I do apologize to everybody for being a few minutes late here. As you can imagine, we're urgently dealing with some things with in Omicron, which makes this a very good starting question.

So well, we don’t know yet, is the short answer. We are looking rapidly to test sera from people who have been vaccinated with our vaccine, as every other manufacturer is, against assays that don't yet exist, which are assays that specifically are for the omicron variant of the virus. We expect to have that data in the coming couple or three weeks, so sometime in the middle of December, and I think that will be a large international effort across all manufacturers and academia and government to try and produce that initial data.

What we know is that our vaccine and others have done a very good job at stopping prior variants, and so there's reasons for some optimism that it will hold up. We were able to with our vaccine 1273 have very

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About MRNA

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on MRNA

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.